IMR Press / RCM / Volume 22 / Issue 3 / DOI: 10.31083/j.rcm2203063
Open Access Editorial
Role of hydroxychloroquine in multidrug treatment of COVID-19
Show Less
1 Truth for Health Foundation, Tucson, AZ, USA
2 Union Square Medical Associates, San Francisco, CA, USA
3 Yale School of Public Health, New Haven, CT 06510, USA
Rev. Cardiovasc. Med. 2021 , 22(3), 545–546; https://doi.org/10.31083/j.rcm2203063
Submitted: 16 September 2021 | Accepted: 17 September 2021 | Published: 24 September 2021
Copyright: © 2021 The Author(s). Published by IMR Press.
This is an open access article under the CC BY 4.0 license (https://creativecommons.org/licenses/by/4.0/).
Abstract

No abstract present.

Keywords
SARS-CoV-2
COVID-19
Hydroxychloroquine
Ambulatory treatment
Mortality
Figures
Fig. 1.
Share
Back to top